HealthTech Innovation Days

Debiopharm Innovation Fund SA

Description

Debiopharm's strategic fund provides funding and guidance for companies with data-driven digital solutions aiming to change the way drugs are developed and the way cancer patients are treated. We invest at Series A and early Seed stages and since 2017, have invested more than USD 100 million in 23 digital health companies. The fund's parent company, Debiopharm develops innovative therapies that respond to high unmet medical needs in oncology and bacterial infections.

Company members

Tom Gibbs